A detailed history of Allspring Global Investments Holdings, LLC transactions in Incyte Corp stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 497,497 shares of INCY stock, worth $35.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
497,497
Previous 892,710 44.27%
Holding current value
$35.3 Million
Previous $54.1 Million 39.23%
% of portfolio
0.05%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$57.33 - $68.61 $22.7 Million - $27.1 Million
-395,213 Reduced 44.27%
497,497 $32.9 Million
Q2 2024

Jul 26, 2024

BUY
$51.18 - $63.75 $25.1 Million - $31.3 Million
490,680 Added 122.05%
892,710 $54.1 Million
Q1 2024

Apr 18, 2024

SELL
$56.55 - $66.59 $20.3 Million - $23.9 Million
-358,330 Reduced 47.13%
402,030 $22.9 Million
Q4 2023

Jan 25, 2024

BUY
$52.16 - $64.19 $13.6 Million - $16.7 Million
259,779 Added 51.9%
760,360 $47.7 Million
Q3 2023

Oct 27, 2023

BUY
$57.77 - $65.93 $28.9 Million - $33 Million
500,581 New
500,581 $28.9 Million
Q2 2023

Jul 18, 2023

SELL
$60.95 - $75.51 $22.4 Million - $27.8 Million
-367,887 Reduced 41.38%
521,074 $32.4 Million
Q1 2023

Apr 13, 2023

BUY
$70.23 - $86.01 $30.6 Million - $37.5 Million
436,345 Added 96.41%
888,961 $64.2 Million
Q4 2022

Jan 23, 2023

SELL
$67.18 - $84.11 $490,884 - $614,591
-7,307 Reduced 1.59%
452,616 $0
Q3 2022

Oct 26, 2022

BUY
$66.18 - $82.86 $29.2 Million - $36.6 Million
441,781 Added 2435.13%
459,923 $30.6 Million
Q2 2022

Jul 25, 2022

SELL
$66.18 - $83.18 $5.28 Million - $6.63 Million
-79,754 Reduced 81.47%
18,142 $1.38 Million
Q1 2022

May 02, 2022

SELL
$66.02 - $79.71 $763,521 - $921,846
-11,565 Reduced 10.57%
97,896 $0
Q4 2021

Jan 28, 2022

BUY
$63.34 - $74.11 $6.93 Million - $8.11 Million
109,461 New
109,461 $8.03 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.